IRIS
SPECIALE, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.347
Totale 1.347
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.347
Totale 1.347
Salva come PNG Salva come JPEG
Città #
Genova 684
Rapallo 253
Genoa 243
Vado Ligure 162
Bordighera 5
Totale 1.347
Salva come PNG Salva come JPEG
Nome #
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma 197
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation 125
Modulazione di CD44/xCT come possibile strategia per contrastare la resistenza all'Etoposide di cellule staminali del cancro 111
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance 101
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 100
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 94
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809 93
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 70
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma 69
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects 68
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 57
“The Blinded Guardian”: clinical relevance of p53-null phenotype in high-grade serous ovarian cancers 56
xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide. 51
Evaluating the influence of a g-quadruplex prone sequence on the transactivation potential by wild-type and/or mutant p53 family proteins through a yeast-based functional assay 45
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 43
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 43
Mutant p53K120R expression enables a partial capacity to modulate metabolism 38
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 22
MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome 20
Totale 1.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.030
article - articoli 5.736
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 0 0 0 0 0 28 44 27 25 46 26 6
2020/2021141 3 9 17 8 9 11 9 19 11 13 23 9
2021/2022221 9 8 17 50 9 13 8 42 12 17 7 29
2022/2023317 20 40 2 47 29 47 0 22 44 2 55 9
2023/2024186 5 18 4 27 24 28 17 15 4 19 9 16
2024/2025174 18 31 10 46 30 39 0 0 0 0 0 0
Totale 1.403